- Home
- DTCK vs CLRB Comparison
DTCK vs CLRB Comparison
Compare DTCK & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTCK
- CLRB
- Stock Information
- Founded
- DTCK 1999
- CLRB 2002
- Country
- DTCK Singapore
- CLRB United States
- Employees
- DTCK N/A
- CLRB 11
- Industry
- DTCK Farming/Seeds/Milling
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- DTCK Industrials
- CLRB Health Care
- Exchange
- DTCK Nasdaq
- CLRB Nasdaq
- Market Cap
- DTCK 12.0M
- CLRB 13.4M
- IPO Year
- DTCK 2023
- CLRB N/A
- Fundamental
- Price
- DTCK $0.70
- CLRB $0.31
- Analyst Decision
- DTCK
- CLRB Hold
- Analyst Count
- DTCK 0
- CLRB 1
- Target Price
- DTCK N/A
- CLRB N/A
- AVG Volume (30 Days)
- DTCK 46.6K
- CLRB 619.8K
- Earning Date
- DTCK 11-13-2024
- CLRB 05-13-2025
- Dividend Yield
- DTCK N/A
- CLRB N/A
- EPS Growth
- DTCK N/A
- CLRB N/A
- EPS
- DTCK 0.02
- CLRB N/A
- Revenue
- DTCK $159,836,000.00
- CLRB N/A
- Revenue This Year
- DTCK N/A
- CLRB N/A
- Revenue Next Year
- DTCK N/A
- CLRB N/A
- P/E Ratio
- DTCK $33.96
- CLRB N/A
- Revenue Growth
- DTCK N/A
- CLRB N/A
- 52 Week Low
- DTCK $0.40
- CLRB $0.22
- 52 Week High
- DTCK $1.73
- CLRB $3.51
- Technical
- Relative Strength Index (RSI)
- DTCK 54.06
- CLRB 52.74
- Support Level
- DTCK $0.48
- CLRB $0.23
- Resistance Level
- DTCK $0.51
- CLRB $0.32
- Average True Range (ATR)
- DTCK 0.08
- CLRB 0.02
- MACD
- DTCK 0.03
- CLRB 0.00
- Stochastic Oscillator
- DTCK 76.40
- CLRB 88.89
About DTCK Davis Commodities Limited
Davis Commodities Ltd is an agricultural commodity trading company based in Singapore which specializes in trading of three main categories of agricultural commodities namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.